Skip to main content

Table 2 Relationship of EET-related gene expression and clinical characteristics of BC patients

From: Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer

Variable

CYP2C8

CYP2C9

CYP2J2

sEH

-

+

P value*

-

+

P value*

-

+

P value*

-

+

P value*

Age, years

≤50

12

4

0.573

8

8

0.292

12

4

0.573

12

10

0.618

 

>50

16

8

 

8

16

 

16

8

 

12

6

 

Histological grade

I

8

2

0.821

8

6

0.879

14

2

0.036

6

4

0.131

II

12

6

 

6

8

 

10

4

 

8

10

 
 

III

8

4

 

2

10

 

4

6

 

10

2

 

Tumor size, cm

≤2

8

0

0.058

6

3

0.089

9

1

0.047

2

7

0.021

 

2-5

18

10

 

10

17

 

17

7

 

20

7

 
 

≥5

2

2

 

0

4

 

2

4

 

2

2

 

Lymph node metastasis

Negative

14

4

0.332

12

12

0.114

19

5

0.166

10

6

0.792

Positive

14

8

 

4

12

 

9

7

 

14

10

 

ER status

-

6

8

0.011

4

10

0.279

8

6

0.193

4

10

0.003

 

+

22

4

 

12

14

 

20

6

 

20

6

 

Ki67 proportion

≤14%

8

8

0.037

2

14

0.007

10

6

0.49

4

12

<0.001

>14%

20

4

 

14

10

 

18

6

 

20

4

 

C-erb-B2 staining

−/+

22

6

0.13

14

14

0.079

24

8

0.221

20

10

0.159

++/+++

6

6

 

2

10

 

4

4

 

4

6

 

PR status

-

6

2

1

2

6

0.439

8

0

0.079

8

5

0.89

 

+

22

10

 

14

18

 

20

12

 

16

11

 
  1. ER, estrogen receptors; PR, progesterone receptor.
  2. *Spearman correlation was used to analyze the correlation of clinicopathological variables and EET-related genes expression.